Task: Answer the multiple choice question.
Question: Which compound exhibits a -14.269% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CCCn1c(O)c(N=NC(=O)c2cccnc2)c2cc(Br)ccc21
b.) CCN1CCN(C(=O)Nc2ccc(OC)cc2OC)CC1
c.) CCN(Cc1nc2ccccc2c(=O)[nH]1)Cc1nc2ccsc2c(=O)[nH]1
Answer: c. CCN(Cc1nc2ccccc2c(=O)[nH]1)Cc1nc2ccsc2c(=O)[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(Cc1nc2ccccc2c(=O)[nH]1)Cc1nc2ccsc2c(=O)[nH]1
CCN(Cc1nc2ccccc2c(=O)[nH]1)Cc1nc2ccsc2c(=O)[nH]1
2-[[ethyl-[(4-oxo-3H-quinazolin-2-yl)methyl]amino]methyl]-3H-thieno[3,2-d]pyrimidin-4-one